{"id":20870,"date":"2022-04-26T08:27:47","date_gmt":"2022-04-26T07:27:47","guid":{"rendered":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-s-a\/"},"modified":"2026-01-28T13:06:20","modified_gmt":"2026-01-28T12:06:20","slug":"marta-grande-de-domingo-takeda-farmaceutica-espana-s-a","status":"publish","type":"post","link":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/","title":{"rendered":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A"},"content":{"rendered":"<p class=\"p1\"><b><img decoding=\"async\" src=\"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56-1024x584.png\" \/><\/b><\/p>\n<h2 class=\"p1\"><b>Resumen de la investigaci\u00f3n\/ innovaci\u00f3n:\u00a0<span class=\"Apple-converted-space\">\u00a0<\/span><\/b><\/h2>\n<p class=\"p3\">Conocer c\u00f3mo los pacientes con Mieloma M\u00faltiple, dada su heterogeneidad, responden al tratamiento pautado en pr\u00e1ctica cl\u00ednica, la duraci\u00f3n real del tratamiento e identificar factores que afectan a la adherencia, son a d\u00eda de hoy necesidades en el \u00e1mbito cl\u00ednico. Con el objetivo de ayudar a los cl\u00ednicos a mejorar el tratamiento de los pacientes y en la toma de decisiones terap\u00e9uticas con iniciativas innovadoras, desde Takeda, en base al convenio establecido con la Universidad de Alcal\u00e1, hemos puesto en marcha un proyecto de investigaci\u00f3n centrado en estudiar la relaci\u00f3n entre la duraci\u00f3n del tratamiento pautado y los resultados de eficacia alcanzados.<span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n<p class=\"p3\">La protecci\u00f3n de la propiedad intelectual en investigaci\u00f3n es crucial y conlleva tareas muy espec\u00edficas de registro del estudio, protocolo y publicaci\u00f3n de resultados. Nos proporciona las herramientas para dar a conocer los resultados de cada iniciativa, protegiendo la creatividad y el dise\u00f1o en las metodolog\u00edas de investigaci\u00f3n.<\/p>\n<p class=\"p3\">Este a\u00f1o el d\u00eda mundial de la propiedad intelectual #WorldIPDay se focaliza en los j\u00f3venes, poniendo de manifiesto los retos a los que tendremos que enfrentarnos en el futuro en base a la evoluci\u00f3n de las alternativas de comunicaci\u00f3n y en los que jugaremos un papel esencial.<\/p>\n<p class=\"p1\"><b>Breve explicaci\u00f3n sobre c\u00f3mo su trabajo contribuye a construir un futuro mejor. Impacto de la investigaci\u00f3n en la vida de las personas.<span class=\"Apple-converted-space\">\u00a0\u00a0<\/span>Llamada a la acci\u00f3n en apoyo a la innovaci\u00f3n y creatividad.<\/b><\/p>\n<p class=\"p3\">Conocer previamente cu\u00e1l ser\u00eda en pr\u00e1ctica cl\u00ednica real el tratamiento m\u00e1s adecuado para cada paciente, en base a sus caracter\u00edsticas cl\u00ednicas y sociodemogr\u00e1ficas, supondr\u00eda una aproximaci\u00f3n innovadora y podr\u00eda ayudar a los cl\u00ednicos a pautar el tratamiento m\u00e1s conveniente a los pacientes afectados con MM y mejorar as\u00ed los resultados alcanzados con su tratamiento. El estudio evaluar\u00e1 a su vez la satisfacci\u00f3n de los pacientes con el tratamiento que est\u00e1n recibiendo, a trav\u00e9s de la recogida del cuestionario TSQM, as\u00ed como la viabilidad de implementaci\u00f3n de este cuestionario en la<span class=\"Apple-converted-space\">\u00a0\u00a0<\/span>pr\u00e1ctica cl\u00ednica habitual, generando as\u00ed mayor conocimiento de la experiencia del paciente en funci\u00f3n del tratamiento recibido y pudiendo mejorar su adherencia.<\/p>\n<h6><b>Link a documentaci\u00f3n o publicaciones del caso concreto de estudio:<\/b><\/h6>\n<p class=\"p5\"><span class=\"s1\"><a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04659798?term=doriant&amp;draw=2&amp;rank=1\">https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04659798?term=doriant&amp;draw=2&amp;rank=1<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resumen de la investigaci\u00f3n\/ innovaci\u00f3n:\u00a0\u00a0 Conocer c\u00f3mo los pacientes con Mieloma M\u00faltiple, dada su heterogeneidad, responden al tratamiento pautado en pr\u00e1ctica cl\u00ednica, la duraci\u00f3n real del tratamiento e identificar factores que afectan a la adherencia, son a d\u00eda de hoy necesidades en el \u00e1mbito cl\u00ednico. Con el objetivo de ayudar a los cl\u00ednicos a mejorar [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":14048,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-20870","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cefi.es\/en\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n\" \/>\n<meta property=\"og:description\" content=\"Resumen de la investigaci\u00f3n\/ innovaci\u00f3n:\u00a0\u00a0 Conocer c\u00f3mo los pacientes con Mieloma M\u00faltiple, dada su heterogeneidad, responden al tratamiento pautado en pr\u00e1ctica cl\u00ednica, la duraci\u00f3n real del tratamiento e identificar factores que afectan a la adherencia, son a d\u00eda de hoy necesidades en el \u00e1mbito cl\u00ednico. Con el objetivo de ayudar a los cl\u00ednicos a mejorar [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/\" \/>\n<meta property=\"og:site_name\" content=\"Centro de estudios para el fomento de la investigaci\u00f3n\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-26T07:27:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-28T12:06:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1243\" \/>\n\t<meta property=\"og:image:height\" content=\"709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Administrador\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Administrador\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/\"},\"author\":{\"name\":\"Administrador\",\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#\\\/schema\\\/person\\\/7f0c55a37796bb7af8bdb655ade37da7\"},\"headline\":\"Marta Grande de Domingo. \\u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A\",\"datePublished\":\"2022-04-26T07:27:47+00:00\",\"dateModified\":\"2026-01-28T12:06:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/\"},\"wordCount\":433,\"publisher\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2022\\\/04\\\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png\",\"articleSection\":[\"Sin categor\u00eda\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/\",\"url\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/\",\"name\":\"Marta Grande de Domingo. \\u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2022\\\/04\\\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png\",\"datePublished\":\"2022-04-26T07:27:47+00:00\",\"dateModified\":\"2026-01-28T12:06:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2022\\\/04\\\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png\",\"contentUrl\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2022\\\/04\\\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png\",\"width\":1243,\"height\":709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cefi.es\\\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cefi.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marta Grande de Domingo. \\u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/cefi.es\\\/en\\\/\",\"name\":\"Centro de estudios para el fomento de la investigaci\u00f3n\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cefi.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#organization\",\"name\":\"Fundacion CeFi. Propiedad industrial e intelectual\",\"url\":\"https:\\\/\\\/cefi.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2019\\\/12\\\/cropped-favicon-3.png\",\"contentUrl\":\"https:\\\/\\\/cefi.es\\\/wp-contenido\\\/uploads\\\/2019\\\/12\\\/cropped-favicon-3.png\",\"width\":512,\"height\":512,\"caption\":\"Fundacion CeFi. Propiedad industrial e intelectual\"},\"image\":{\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cefi.es\\\/en\\\/#\\\/schema\\\/person\\\/7f0c55a37796bb7af8bdb655ade37da7\",\"name\":\"Administrador\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g\",\"caption\":\"Administrador\"},\"url\":\"https:\\\/\\\/cefi.es\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cefi.es\/en\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/","og_locale":"en_US","og_type":"article","og_title":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n","og_description":"Resumen de la investigaci\u00f3n\/ innovaci\u00f3n:\u00a0\u00a0 Conocer c\u00f3mo los pacientes con Mieloma M\u00faltiple, dada su heterogeneidad, responden al tratamiento pautado en pr\u00e1ctica cl\u00ednica, la duraci\u00f3n real del tratamiento e identificar factores que afectan a la adherencia, son a d\u00eda de hoy necesidades en el \u00e1mbito cl\u00ednico. Con el objetivo de ayudar a los cl\u00ednicos a mejorar [&hellip;]","og_url":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/","og_site_name":"Centro de estudios para el fomento de la investigaci\u00f3n","article_published_time":"2022-04-26T07:27:47+00:00","article_modified_time":"2026-01-28T12:06:20+00:00","og_image":[{"width":1243,"height":709,"url":"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png","type":"image\/png"}],"author":"Administrador","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Administrador","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#article","isPartOf":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/"},"author":{"name":"Administrador","@id":"https:\/\/cefi.es\/en\/#\/schema\/person\/7f0c55a37796bb7af8bdb655ade37da7"},"headline":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A","datePublished":"2022-04-26T07:27:47+00:00","dateModified":"2026-01-28T12:06:20+00:00","mainEntityOfPage":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/"},"wordCount":433,"publisher":{"@id":"https:\/\/cefi.es\/en\/#organization"},"image":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#primaryimage"},"thumbnailUrl":"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png","articleSection":["Sin categor\u00eda"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/","url":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/","name":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A - Centro de estudios para el fomento de la investigaci\u00f3n","isPartOf":{"@id":"https:\/\/cefi.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#primaryimage"},"image":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#primaryimage"},"thumbnailUrl":"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png","datePublished":"2022-04-26T07:27:47+00:00","dateModified":"2026-01-28T12:06:20+00:00","breadcrumb":{"@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#primaryimage","url":"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png","contentUrl":"https:\/\/cefi.es\/wp-contenido\/uploads\/2022\/04\/Captura-de-Pantalla-2022-04-25-a-las-19.59.56.png","width":1243,"height":709},{"@type":"BreadcrumbList","@id":"https:\/\/cefi.es\/marta-grande-de-domingo-takeda-farmaceutica-espana-sa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cefi.es\/en\/"},{"@type":"ListItem","position":2,"name":"Marta Grande de Domingo. \u2028Takeda Farmac\u00e9utica Espa\u00f1a S.A"}]},{"@type":"WebSite","@id":"https:\/\/cefi.es\/en\/#website","url":"https:\/\/cefi.es\/en\/","name":"Centro de estudios para el fomento de la investigaci\u00f3n","description":"","publisher":{"@id":"https:\/\/cefi.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cefi.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cefi.es\/en\/#organization","name":"Fundacion CeFi. Propiedad industrial e intelectual","url":"https:\/\/cefi.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cefi.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/cefi.es\/wp-contenido\/uploads\/2019\/12\/cropped-favicon-3.png","contentUrl":"https:\/\/cefi.es\/wp-contenido\/uploads\/2019\/12\/cropped-favicon-3.png","width":512,"height":512,"caption":"Fundacion CeFi. Propiedad industrial e intelectual"},"image":{"@id":"https:\/\/cefi.es\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cefi.es\/en\/#\/schema\/person\/7f0c55a37796bb7af8bdb655ade37da7","name":"Administrador","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca0778ec401a3f547a961e1de7e04c284c1c4dbcf95f7dc69f9bae782d89953c?s=96&d=mm&r=g","caption":"Administrador"},"url":"https:\/\/cefi.es\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/posts\/20870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/comments?post=20870"}],"version-history":[{"count":3,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/posts\/20870\/revisions"}],"predecessor-version":[{"id":26306,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/posts\/20870\/revisions\/26306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/media\/14048"}],"wp:attachment":[{"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/media?parent=20870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/categories?post=20870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cefi.es\/en\/wp-json\/wp\/v2\/tags?post=20870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}